Pancreatic cancer

Pancreatic cancer

Epidemiology:

Pancreatic cancer is a formidable malignancy with an incidence rate of approximately 13.5 cases per 100,000 individuals annually in the United States, making it one of the most aggressive cancers worldwide ¹. Despite extensive research and advances in therapeutic interventions, spontaneous remission (SR) from this disease is exceptionally rare, occurring in less than 1% of patients diagnosed with malignant pancreatic neoplasms ¹. Documented cases of SR are typically characterized by unexpected and profound improvements in symptoms or tumor burden, further complicating the accurate assessment of their prevalence and mechanisms ². As a consequence, the identification of SR in pancreatic cancer remains a challenge, as such cases often surface unpredictably and defy conventional prognostic expectations ¹.

Clinical Characteristics:

To date, there have been twelve reported cases of spontaneous regression (SR) involving primary or metastatic pancreatic tumors. Several clinical patterns have been observed among these cases. The patients’ ages at the time of regression ranged from 13 to 77 years, with a predominance observed in males (2:1 ratio). The duration of follow-up ranged from 6 weeks to 13 years. See Table 1 below for further information

Histological Characteristics:

Of the cases analyzed, the histology of the tumors was primarily reported as originating from the pancreas, with most identified as solid or cystic pancreatic lesions. Instances of non-pancreatic malignancies, including extrapancreatic or unrelated tumor types, were excluded from this data collection to ensure diagnostic consistency.

Proposed Contributing Mechanisms:

Among the reported cases, proposed mechanisms varied considerably. Several reports attributed regression to immune or inflammatory responses, hormonal influences, or degenerative changes within the tumor, while others described spontaneous resolution without identifiable contributing factors. A few cases emphasized the role of host immune regulation in mediating tumor regression. The remaining reports did not specify any therapeutic or mechanistic associations. Collectively, these findings suggest that immune activity, hormonal modulation, and degenerative processes may contribute to the spontaneous regression of pancreatic tumors.

Site and Extent of Remission:

The majority of documented cases exhibited complete regression of the primary pancreatic lesion, whereas several others demonstrated remission at metastatic sites such as the liver and lymph nodes. One patient-maintained remission for over a decade, indicating durable disease control. Although follow-up data are limited, these findings suggest that spontaneous regression in pancreatic tumors can occasionally result in sustained remission.

Table 1: Pancreatic cancer SR Cases and Clinical Characteristics

References:

1. Huang J., Lok V., Ngai C., et al. Worldwide burden of, risk factors for, and trends in pancreatic cancer. Gastroenterology. 2021;160(3):744-754. doi:10.1053/j.gastro.2020.10.007
2. Trajkovic‐Arsic M., Kalideris E., & Siveke J. The role of insulin and igf system in pancreatic cancer. Journal of Molecular Endocrinology. 2013;50(3):R67-R74. doi:10.1530/jme-12-0259
3. Melnyk CS, Krippaehne WW, Benson JA Jr, Dunphy JE. Spontaneous remission of Zollinger-Ellison syndrome. Arch Intern Med. 1965;115:42-47.
4. Shapiro SL. Spontaneous regression of cancer. Eye Ear Nose Throat Mon. 1967;46(10):1306-1310.
5. Tchertkoff V, Hauser AD. Carcinoma of head of pancreas with spontaneous regression. N Y State J Med. 1974;74(10):1814.
6. Nakahara K, Kobayashi G, Fujita N, et al. Solid-pseudopapillary tumor of the pancreas showing a remarkable reduction in size over the 10-year follow-up period. Intern Med. 2008;47(14):1335-1339. doi:10.2169/internalmedicine.47.0767
7. Suzuki M, Shimizu T, Minowa K, Ikuse T, Baba Y, Ohtsuka Y. Spontaneous shrinkage of a solid pseudopapillary tumor of the pancreas: CT findings. Pediatr Int. 2010;52(2):335-336. doi:10.1111/j.1442-200X.2010.03039.x
8. Nakata B, Amano R, Matsuoka J, et al. Spontaneously complete regression of pseudolymphoma of the remnant pancreas after pancreaticoduodenectomy. Pancreatology. 2012;12(3):215-218. doi:10.1016/j.pan.2012.02.011
9. Yoon HJ, Lim JH. Solid pseudopapillary tumor of the pancreas with hepatic metastasis: spontaneous regression over 10-year follow-up period. Korean J Radiol. 2012;13(5):648-651. doi:10.3348/kjr.2012.13.5.648
10. Chin KM, Chan CY, Lee SY. Spontaneous regression of pancreatic cancer: a case report and literature review. Int J Surg Case Rep. 2018;42:55-59. doi:10.1016/j.ijscr.2017.11.056
11. Ibrahimi S, Mukherjee S, Alhyari L, Rubin E, Aljumaily R. Spontaneous regression of metastatic pancreatic cancer: a role for recurrent inflammation. Pancreas. 2019;48(1):e4-e6. doi:10.1097/MPA.0000000000001193
12. Saade Lemus P, Anderson K, Smith M, Bullock A. Spontaneous regression of pancreatic cancer with liver metastases. BMJ Case Rep. 2019;12(5):e229619. doi:10.1136/bcr-2019-229619
13. Yasuda H, Kataoka K, Miyake H, Sogame Y, Sakagami J, Yasukawa S, Konishi E, Yanagisawa A, Itoh Y. Spontaneous regression in solid pseudopapillary neoplasm of pancreas. Clin J Gastroenterol. 2023;16(1):105-109. doi:10.1007/s12328-022-01715-4
14. Sano, I., Kuwatani, M., Sugiura, R., Kato, S., Kawakubo, K., Ueno, T., Nakanishi, Y., Mitsuhashi, T., Hirata, H., Haba, S., Hirano, S., & Sakamoto, N. (2017). Hepatobiliary and Pancreatic: A rare case of a well-differentiated neuroendocrine tumor in the bile duct with spontaneous regression diagnosed by EUS-FNA. Journal of gastroenterology and hepatology, 32(1), 11. https://doi.org/10.1111/jgh.13585
15. Li, X., & Liu, Y. (2022). Spontaneous regression of solid-pseudopapillary neoplasms with hepatic metastases. Hepatobiliary surgery and nutrition, 11(1), 169–170. https://doi.org/10.21037/hbsn-21-438
16. Matsubayashi, H., Uesaka, K., Sasaki, K., Shimada, S., Takada, K., Ishiwatari, H., & Ono, H. (2019). A Pancreatic Inflammatory Myofibroblastic Tumor with Spontaneous Remission: A Case Report with a Literature Review. Diagnostics (Basel, Switzerland), 9(4), 150. https://doi.org/10.3390/diagnostics9040150